NACA Assures Nigerians of Steady Supply of HIV Drugs
The National Agency for the Control of AIDS (NACA) has assured Nigerians, especially those living with HIV, that there is no shortage of antiretroviral drugs in the country.
This reassurance follows concerns raised after a recent World Health Organisation (WHO) press conference. In response, NACA emphasized that the Federal Government is taking proactive measures to ensure a continuous supply of HIV medication across the nation.
The agency outlined key government actions, including the approval of $1.07 billion by the Federal Executive Council (FEC) for healthcare reforms under the Human Capital Opportunities for Prosperity and Equity (HOPE) program. Furthermore, N4.8 billion has been allocated specifically for HIV treatment, and the Nigerian Senate recently approved an additional N300 billion for the health sector in the 2025 budget.
Dr. Temitope Ilori, the Director-General of NACA, explained that these financial commitments are designed to mitigate the impact of the temporary pause on aid from the United States government. This ensures that Nigeria’s HIV response remains unaffected and continues uninterrupted.
While acknowledging the longstanding partnership with the US government, NACA emphasized that this situation presents an opportunity to strengthen local resource mobilization and enhance the sustainability of HIV programs in the country.
“There is no shortage of drugs and consumables, and no immediate cessation of HIV treatment, testing, and prevention services in Nigeria. Our treatment centers and pharmacies will continue to have a sufficient supply of antiretroviral drugs, ensuring uninterrupted access to care,” Dr. Ilori reassured Nigerians.
NACA reiterated its commitment to the fight against HIV/AIDS, pledging continued access to quality prevention, treatment, and care services for all Nigerians.
